Clean Science

Why is Clean Science & Technology Ltd falling/rising?

As of 15-Jun, Clean Science & Technology Ltd's stock price is rising to Rs 791.40, with a 2.62% increase today and a total return of 6.6% over the last two days. Despite a year-to-date decline of 9.82%, recent positive investor sentiment and increased participation are driving the current upward trend.

As of 15-Jun, Clean Science & Technology Ltd's stock price is rising, currently at Rs 791.40, reflecting an increase of Rs 20.2 or 2.62%. The stock has shown a positive performance today, outperforming its sector by 0.89% and has been on a consecutive gain for the last two days, accumulating a total return of 6.6% during this period. Additionally, the stock reached an intraday high of Rs 817, marking a rise of 5.94%.<BR><BR>Investor participation appears to be increasing, as evidenced by a significant rise in delivery volume, which increased by 65.22% compared to the 5-day average. The stock's liquidity is also favorable, being liquid enough for a trade size of Rs 0.23 crore based on 2% of the 5-day average traded value.<BR><BR>Despite the stock's recent gains, it is important to note that it has faced challenges over the longer term, with a year-to-date decline of 9.82% and a substantial drop of 45.79% over the past year. However, the current upward movement can be attributed to short-term factors such as improved investor sentiment, rising participation, and recent performance metrics that indicate a positive trend.

Which are the latest news on Clean Science?

What does Clean Science do?

Clean Science and Technology Ltd is a small-cap company in the specialty chemicals industry, reporting net sales of ₹249 Cr and a net profit of ₹58 Cr for March 2026. Key metrics include a P/E ratio of 35.00 and a market cap of ₹8,202 Cr.

Overview:<BR>Clean Science and Technology Ltd operates in the specialty chemicals industry and is categorized as a small-cap company.<BR><BR>History:<BR>The company was originally incorporated as 'Sri Distikemi Private Limited' in 2003 and later changed its name to 'Clean Science and Technology Private Limited' in 2006. The latest quarterly results reported net sales and net profit for March 2026.<BR><BR>Financial Snapshot:<BR>Net Sales: 249 Cr (Quarterly Results - Mar 2026) <BR>Net Profit: 58 Cr (Quarterly Results - Mar 2026) <BR>Market Cap: INR 8,202 Cr (Small Cap)<BR><BR>Key Metrics:<BR>P/E: 35.00 <BR>Industry P/E: 42 <BR>Dividend Yield: 0.78% <BR>Debt-Equity: -0.24 <BR>Return on Equity: 14.50% <BR>Price to Book: 5.15 <BR><BR>Contact Details:<BR>No Company Details Available <BR>Registrar Address: Not available.

How big is Clean Science?

As of 10th June, Clean Science & Technology Ltd has a market capitalization of 8,202.00 Cr, with recent net sales of 956.54 Cr and a net profit of 229.64 Cr. The latest balance sheet shows shareholder's funds of 1,416.42 Cr and total assets of 1,599.51 Cr.

As of 10th June, Clean Science & Technology Ltd has a market capitalization of 8,202.00 Cr, categorizing it as a Small Cap company.<BR><BR>In the latest four quarters, the company reported Net Sales of 956.54 Cr and a Net Profit of 229.64 Cr.<BR><BR>The latest annual period for the balance sheet is March 2025, showing Shareholder's Funds of 1,416.42 Cr and Total Assets of 1,599.51 Cr.

Who are in the management team of Clean Science?

The management team of Clean Science includes Pradeep R Rathi (Chairman), Ashok Ramnarayan Boob (Managing Director), Krishnakumar Ramnarayan Boob (Whole-time Director), Sanjay Kothari (Director), and several independent directors, along with Mahesh Arvind Kulkarni (Company Secretary) and Siddhartha Ashok Sikchi (Whole-time Director). They oversee the company's strategic direction and operations.

The management team of Clean Science includes the following individuals:<BR><BR>1. **Pradeep R Rathi** - Chairman & Non-Executive Director<BR>2. **Ashok Ramnarayan Boob** - Managing Director<BR>3. **Krishnakumar Ramnarayan Boob** - Whole-time Director<BR>4. **Sanjay Kothari** - Director<BR>5. **Ganapati D Yadav** - Independent Director<BR>6. **Keval Navinchandra Doshi** - Independent Director<BR>7. **Madhu Dubhashi** - Independent Director<BR>8. **Mahesh Arvind Kulkarni** - Company Secretary & Compliance Officer<BR>9. **Siddhartha Ashok Sikchi** - Whole-time Director<BR><BR>This team is responsible for guiding the company's strategic direction and operations.

Who are the peers of the Clean Science?

Clean Science's peers include Anupam Rasayan, Vinati Organics, Privi Speciality, Jubilant Ingrevia, Alkyl Amines, Elantas Beck, Balaji Amines, Archean Chemical, Galaxy Surfactants, and Neogen Chemicals. Clean Science has the lowest 1-year return at -50.53%, while Privi Speciality leads with a 40.25% return.

Peers: The peers of Clean Science are Anupam Rasayan, Vinati Organics, Privi Speci., Jubilant Ingrev., Alkyl Amines, Elantas Beck, Balaji Amines, Archean Chemical, Galaxy Surfact., and Neogen Chemicals.<BR><BR>Quality Snapshot: Excellent management risk is observed at Clean Science, Vinati Organics, Privi Speci., Jubilant Ingrev., Alkyl Amines, Elantas Beck, Archean Chemical, and the rest. Below Average management risk is found at Anupam Rasayan and Galaxy Surfact., while Average management risk is noted for Balaji Amines and Neogen Chemicals. Growth ratings show that Clean Science, Anupam Rasayan, Vinati Organics, Jubilant Ingrev., Alkyl Amines, Elantas Beck, Balaji Amines, Archean Chemical, and Galaxy Surfact. have Below Average growth, while Privi Speci. and the rest have Average growth. Capital Structure ratings indicate that Clean Science, Vinati Organics, Jubilant Ingrev., Alkyl Amines, Elantas Beck, Balaji Amines, Archean Chemical, and Galaxy Surfact. have Excellent capital structure, while Anupam Rasayan and Neogen Chemicals have Average and Below Average capital structure, respectively.<BR><BR>Return Snapshot: Privi Speci. has the highest 1-year return at 40.25%, while Clean Science has the lowest at -50.53%. Clean Science's 1-year return is significantly lower than all its peers. Additionally, the six-month return is negative for Clean Science, Vinati Organics, Elantas Beck, Archean Chemical, and Galaxy Surfact.

Are Clean Science & Technology Ltd latest results good or bad?

Clean Science & Technology Ltd's latest results show a sequential recovery with a 13.47% QoQ revenue increase and a 27.01% rise in net profit, but year-on-year declines of 5.47% in revenue and 21.35% in net profit indicate ongoing challenges. Investors should monitor these mixed results closely as the company faces competitive pressures.

Clean Science & Technology Ltd's latest results present a mixed picture. On one hand, the company has shown a sequential recovery in its financial performance, with a 13.47% increase in revenue quarter-on-quarter (QoQ) to ₹249.25 crores and a 27.01% rise in net profit to ₹58.27 crores. This indicates improving demand conditions and effective cost management, as reflected in the significant expansion of operating margins to 38.42%.<BR><BR>However, the year-on-year (YoY) performance raises concerns, as both revenue and net profit have declined by 5.47% and 21.35%, respectively. This marks the third consecutive quarter of YoY underperformance, suggesting that the company is struggling to regain its previous levels of profitability in a competitive specialty chemicals market.<BR><BR>Overall, while the sequential improvements are encouraging, the persistent YoY declines indicate underlying challenges that could affect the company's future growth prospects. Investors may want to monitor these trends closely, as the company navigates through these mixed results.

Should I buy, sell or hold Clean Science & Technology Ltd?

Has Clean Science & Technology Ltd declared dividend?

Yes, Clean Science & Technology Ltd has declared a dividend of 200%, amounting to ₹4 per share, with an ex-date of February 6, 2026. However, the company's stock has experienced significant negative returns over various periods, indicating challenging performance despite the dividend.

Clean Science & Technology Ltd has declared a dividend.<BR><BR>Dividend Details:<BR>- Percentage announced: 200%<BR>- Amount per share: 4 per share<BR>- Ex-date: 06 Feb 26<BR><BR>Dividend Yield: 0.7%.<BR><BR>Total Returns by Period:<BR>In the 3-month period, the price return was -20.27%, the dividend return was 0.20%, resulting in a total return of -20.07%.<BR><BR>In the 6-month period, the price return was -35.02%, the dividend return was 0.49%, leading to a total return of -34.53%.<BR><BR>For the 1-year period, the price return was -40.82%, the dividend return was 0.55%, culminating in a total return of -40.27%.<BR><BR>Over the 2-year period, the price return was -42.37%, the dividend return was 0.57%, resulting in a total return of -41.8%.<BR><BR>In the 3-year period, the price return was -39.38%, the dividend return was 0.90%, leading to a total return of -38.48%.<BR><BR>For the 4-year period, the price return was -64.48%, the dividend return was 0.98%, culminating in a total return of -63.5%.<BR><BR>In the 5-year period, the price return was 0%, the dividend return was 0%, resulting in a total return of 0.0%.<BR><BR>Overall, while Clean Science & Technology Ltd has declared a substantial dividend, the total returns over various periods indicate significant negative performance, particularly in the longer term. The dividend yield is modest, suggesting that despite the dividend declaration, the company's stock performance has been challenging.

How has been the historical performance of Clean Science?

Clean Science has shown consistent growth in net sales and profitability, with net sales increasing from 419.30 Cr in March 2020 to 966.64 Cr in March 2025, despite a dip in March 2023. The company also demonstrated strong earnings growth, with profit before tax reaching 356.73 Cr and earnings per share rising to 24.87 in March 2025.

Answer:<BR>The historical performance of Clean Science shows a consistent growth trajectory in net sales and profitability over the years.<BR><BR>Breakdown:<BR>Clean Science has demonstrated significant growth in net sales, increasing from 419.30 Cr in March 2020 to 966.64 Cr in March 2025, with a notable dip in March 2023 at 935.80 Cr. The total operating income followed a similar trend, reaching 966.64 Cr in March 2025. The raw material costs have also risen, from 127.98 Cr in March 2020 to 368.34 Cr in March 2025, while total expenditure (excluding depreciation) increased from 234.02 Cr to 579.02 Cr over the same period. Operating profit (PBDIT) peaked at 512.33 Cr in March 2023 but fell to 426.21 Cr in March 2025. Profit before tax showed a steady increase, reaching 356.73 Cr in March 2025, while profit after tax was 264.41 Cr. The earnings per share (EPS) rose from 13.12 in March 2020 to 24.87 in March 2025, despite a peak of 35.37 in March 2023. The company's total assets grew significantly from 429.88 Cr in March 2020 to 1,599.51 Cr in March 2025, with total liabilities also increasing from 429.88 Cr to 1,599.51 Cr. Cash flow from operating activities improved to 213.00 Cr in March 2025, while the net cash inflow was 9.00 Cr, indicating a positive cash position. Overall, Clean Science has shown robust growth in both revenue and profitability, alongside a solid asset base.

Is Clean Science technically bullish or bearish?

As of August 25, 2025, the technical trend has shifted to a moderately strong bearish stance, indicated by bearish signals from MACD, moving averages, Bollinger Bands, KST, and OBV, along with significant underperformance compared to the Sensex.

As of 25 August 2025, the technical trend has changed from mildly bearish to bearish. The current stance is bearish with a moderate strength. Key indicators driving this include a bearish MACD on the weekly chart, a bearish moving average on the daily timeframe, and a bearish reading from Bollinger Bands on the monthly chart. Additionally, the KST and OBV both indicate bearish conditions on the monthly timeframe. The stock has underperformed significantly compared to the Sensex over multiple periods, further supporting the bearish outlook.

Who are the top shareholders of the Clean Science?

The top shareholders of Clean Science include promoter Ashok Ramnarayan Boob with 12.8%, 16 mutual fund schemes holding 4.48%, 92 foreign institutional investors with 6.07%, and the highest public shareholder, Anantroop Financial Advisory Services Private Limited, at 3.92%. Individual investors collectively own 7.78% of the shares.

The top shareholders of Clean Science include the promoters, who hold the majority of the shares. The promoter with the highest holding is Ashok Ramnarayan Boob, owning 12.8% of the company. Additionally, there are 16 mutual fund schemes that collectively hold 4.48%, and 92 foreign institutional investors (FIIs) with a combined holding of 6.07%. The highest public shareholder is Anantroop Financial Advisory Services Private Limited, which holds 3.92%. Individual investors also have a notable stake, accounting for 7.78% of the shares.

Is Clean Science overvalued or undervalued?

As of September 17, 2021, Clean Science is considered overvalued with a PE ratio of 60.69, significantly higher than its peers, and despite a 12.71% return over the past year, it is trading at a premium compared to its earnings and growth potential.

As of 17 September 2021, the valuation grade for Clean Science has moved from does not qualify to very expensive, indicating a significant shift in its perceived value. The company is currently considered overvalued. Key ratios include a PE ratio of 60.69, an EV to EBITDA of 40.46, and a PEG ratio of 7.28, all of which suggest that the stock is trading at a premium compared to its earnings and growth potential.<BR><BR>In comparison to its peers, Clean Science's PE ratio is notably higher than Godrej Industries Ltd., which has a PE of 46.63 and is rated as attractive, and Deepak Nitrite Ltd., with a PE of 37.97 and also rated very expensive. This disparity highlights Clean Science's overvaluation relative to its industry peers. Additionally, while Clean Science has shown a 12.71% return over the past year, this is less impressive compared to the Sensex's 7.55% return, reinforcing the notion that the stock may not be justifiably priced at its current levels.

When is the next results date for Clean Science?

No Upcoming Board Meetings